Related Experiment Videos
Biosynthesis of human von Willebrand factor
1Department of Molecular Biology, Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Haemostasis
|January 1, 1988
Summary
The endothelium synthesizes von Willebrand factor (vWF), a key protein for platelet adhesion. Understanding vWF biosynthesis, multimer assembly, and secretion is crucial for hemostasis and vascular injury response.
Area of Science:
- Vascular Biology
- Hemostasis and Thrombosis
- Cellular and Molecular Biology
Background:
- The endothelium lines blood vessels, directly interacting with blood and modulating coagulation and fibrinolysis.
- Endothelial cells synthesize and secrete hemostatic factors, including von Willebrand factor (vWF).
- vWF is essential for platelet adhesion to the vessel wall following injury.
Purpose of the Study:
- To elucidate the biosynthetic pathway of von Willebrand factor (vWF).
- To understand the complex processing, multimer assembly, and secretion mechanisms of vWF by endothelial cells.
- To predict the sequential events involved in vWF production and release.
Main Methods:
- Review of existing data on vWF biosynthesis and processing.
- Analysis of vWF structure, including multimerization and disulfide bonding.
- Investigation of vWF secretion pathways (constitutive vs. stimulated release).
Main Results:
- vWF is synthesized as a pre-pro-polypeptide that assembles into multimers.
- The pro-polypeptide can be cleaved, yielding von Willebrand antigen II.
- vWF multimer size correlates with hemostatic potency, making assembly critical.
Conclusions:
- The multimeric assembly of vWF is a crucial aspect of its biosynthesis.
- Endothelial cells can either constitutively secrete vWF or store and release it upon stimulation.
- A sequential model for vWF biosynthesis, processing, multimer assembly, and secretion has been proposed.